Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AstraZeneca Offloads Phase III-Ready Su
The Netherlands-based European life sciences investment group, LSP (Life Sciences Partners) has raised $280m for its fifth life sciences venture fund, in an over-subscribed final closing that benefite
IN VITRO DIAGNOSTICS Alliances AEterna Zentaris Inc. Armune BioScience Inc. Armune BioScience Inc. granted AEterna Zentaris Inc. rights to sell its Apifiny prostate cancer diagnostic to desi